Ebola Vaccine: How Far are we?

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 5

Abstract

Ebola viruses have been identified as an emerging threat as it causes severe haemorrhagic fever in human with mortality rates ranging from 50 to 90%. In addition to being a global health concern, the virus also is considered a potential biological threat agent. As for now, no licensed vaccine is available for pre or post exposure treatment. Recent epidemic of this disease in South Africa has led to concern towards development of an effective vaccine on a priority basis. This review is an attempt to look upon current progress in the development of Ebola virus vaccines and highlights strategies that have the greatest potential for commercial development.

Authors and Affiliations

Rajani Sharma, Ketki Jangid, Dr. Anuradha

Keywords

Related Articles

Correlates and Predictors of Resilience among Baccalaureate Nursing Students

Introduction: A growing body of literature recognizes the importance of resilience in the nursing profession. Both mindfulness and resilience aid in handling stress, stress increases the risk of rumination and/or worry e...

Serum Adiponectin Levels in Insulin Resistant Infertile Women

ABSTRACT Introduction: Adiponectin, a beneficial adipocytokine plays a crucial role that regulates insulin sensitivity and also has a role in the ovulation process. Visceral adiposity adversely affects the reproductive...

Autism Spectrum DisordersAetiopathogenesis

Autism Spectrum Disorders (ASD) are characterised by a range of clinical features that can vary from individual to individual in both degree of severity and variability of the clinical presentation. The aetiology or caus...

Overjet Reduction with the Use of ELIBA Device: A Case Report

ABSTRACT The dental overjet, in subjects with skeletal class II, division I, malocclusion represents one of the difficult problems to resolve for the orthodontist. We describe a case of dental overjet reduction, treated...

Download PDF file
  • EP ID EP341305
  • DOI 10.7860/JCDR/2017/22184.9863
  • Views 78
  • Downloads 0

How To Cite

Rajani Sharma, Ketki Jangid, Dr. Anuradha (2017). Ebola Vaccine: How Far are we?. Journal of Clinical and Diagnostic Research, 11(5), 1-4. https://europub.co.uk/articles/-A-341305